Osteoporosis prevention strategies and new bone research focus of major Hong Kong meeting

December 12, 2013

Today, one of the largest clinical bone events in the Asia-Pacific region opened at the Hong Kong Conference and Exhibition Centre, drawing close to 850 international delegates from over 60 countries. The IOF Regionals 4th Asia-Pacific Osteoporosis Meeting, which continues through to December 15, is organized by the International Osteoporosis Foundation (IOF) in cooperation with the Hong Kong Osteoporosis Foundation and the Osteoporosis Society of Hong Kong.

The Meeting focuses on the latest prevention and management strategies in the battle against osteoporosis, one of the most common and serious chronic diseases affecting older adults in Asia. It is estimated that one in three women and one in five men over the age of 50 will suffer a fracture due to osteoporosis. Fractures caused by osteoporosis, particularly those of the hip and spine, are a major cause of disability in senior citizens, often resulting in long-term disability, loss of independence, and sometimes premature death.

Judy Stenmark, CEO, IOF stated, "We're pleased to host this important annual Meeting in Hong Kong. Delegates from many different specializations will have a unique opportunity to interact with renowned bone experts and exchange information with their peers. They will hear about the latest disease-management options and other clinical advances which will be of benefit to their patients."

A new Audit report launched earlier today by the IOF reveals that in Hong Kong alone there will be an approximate 70% increase in the number of hip fractures from 2009 to 2015. To stem this tide of fractures, health professionals and health authorities must implement new prevention strategies and engage in more research.

"More than 230 research abstracts will be published in conjunction with the IOF Asia-Pacific Osteoporosis Meeting, and many of these present important new findings from Asian countries. This underlines the significance of IOF's annual meeting as a fertile venue for collaboration and research innovation," said Professor Cyrus Cooper, Co-Chair of the Meeting and Chair, IOF Committee of Scientific Advisors.

The scientific abstracts from the Asia-Pacific Osteoporosis Meeting have been published in a supplement issue of Osteoporosis International.
-end-
Notes to Editors

The IOF Regionals 5th Asia-Pacific Osteoporosis Meeting is scheduled to take place in Taipei, from November 14-17, 2014.

About IOF

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 200 patient, medical and research societies, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org; http://www.facebook.com/iofbonehealth;http://www.twitter.com/iofbonehealth Information about IOF Scientific Meetings and Training Courses is available at http://www.iofbonehealth.org/upcoming-events

Media contact

Charanjit K. Jagait, PhD
Communications Director, International Osteoporosis Foundation
Tel.: +41 22 994 01 02 • Mob.: +41 79 874 52 08 • Email: cjagait@iofbonehealth.org

International Osteoporosis Foundation

Related Osteoporosis Articles from Brightsurf:

New opportunities for detecting osteoporosis
Osteoporosis can be detected through low dose computed tomography (LDCT) imaging tests performed for lung cancer screening or other purposes.

Oxytocin can help prevent osteoporosis
In a laboratory experiment with rats, Brazilian researchers succeeded in reversing natural processes associated with aging that lead to loss of bone density and strength.

New strategy against osteoporosis
An international research team has found a new approach that may be able to reduce bone loss in osteoporosis and maintain bone health.

New review on management of osteoporosis in premenopausal women
An IOF and ECTS Working Group have published an updated review of literature published after 2017 on premenopausal osteoporosis.

Cardiac CT can double as osteoporosis test
Cardiac CT exams performed to assess heart health also provide an effective way to screen for osteoporosis, potentially speeding treatment to the previously undiagnosed, according to a new study.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

A link between mitochondrial damage and osteoporosis
In healthy people, a tightly controlled process balances out the activity of osteoblasts, which build bone, and osteoclasts, which break it down.

Many stroke patients not screened for osteoporosis, despite known risks
Many stroke survivors have an increased risk of osteoporosis, falls or breaks when compared to healthy people.

Many postmenopausal women do not receive treatment for osteoporosis
The benefits of treating osteoporosis in postmenopausal women outweigh the perceived risks, according to a Clinical Practice Guideline issued today by the Endocrine Society.

Read More: Osteoporosis News and Osteoporosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.